OncoResponse Appoints Chris Russell as Chief Financial Officer
May 11, 2021 07:00 ET | OncoResponse, Inc.
SEATTLE, May 11, 2021 (GLOBE NEWSWIRE) -- OncoResponse, a biotechnology company harnessing the power of the human immune system to identify and develop novel monoclonal antibodies to...
OncoResponse Raises $40.6 Million Series C Financing
March 31, 2021 07:00 ET | OncoResponse, Inc.
- New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies - Adds Magnetar Group, Yonjin Ventures and Bering Capital to the syndicate SEATTLE, March 31, 2021 (GLOBE...